A recent study involving RNA-seq data sets revealed that CMTM6 expression is correlated with poor prognosis in human gliomas, possibly due to the inhibition of T-lymphocyte-mediated antitumor immunity (32). This evidence concerns the gene CMTM6 and central nervous system cancer.